Hepatitis Delta Risk Study in Hepatitis B Patients
Part of Digestive system, Infections clinical trials.
This study looks for hepatitis delta virus (a virus that only affects people with hepatitis B) in patients who have chronic hepatitis B. Researchers want to understand how common this co-infection is and which patients are at highest risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older
- You have been diagnosed with chronic hepatitis B (either confirmed by blood tests showing HBsAg positive for at least 6 months, or a specific pattern of hepatitis B antibodies)
- You are willing to have blood drawn for testing at one of the participating hospitals in Ho Chi Minh City or Hanoi
- You are willing to sign a consent form agreeing to participate
- You may have other liver conditions like cirrhosis or hepatocellular carcinoma (liver cancer), but it is not required
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
This study looks at how a specific protein (ANKRD11) affects immune cells in people with chronic hepatitis B. By understanding this, researchers hope to find ways to help your immune system fight the virus better.
This study looks at how hepatitis B virus changes in your body, including mutations and drug resistance, using your blood or liver tissue samples. Understanding these changes could help improve treatment for hepatitis B.
This study follows adults who have ongoing hepatitis D infection along with hepatitis B. It aims to better understand this mixed infection and how these patients do over time.
This study tests whether people with both HIV and chronic hepatitis B should be checked for a third liver virus called HDV (hepatitis D). It helps find hidden infections so they can get the right care.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.